GSE114648
Epigenetic drugs selectively target a population of AML cells which are positive for CD123 cell surface markers and are chemoresistant II
Gene expression profiling was performed on OCI-AML2 R50 drug resistant leukemia cell line before or after Romidepsin treatment. Overall design: mRNA profiles of OCI-AML2 R50 cells with or without Romidepsin treatment